 |
|
Today the FDA has granted accelerated approval to Pfizer’s HIV medicine Selzentry (or maraviroc). Hill & Knowlton has been assisting Pfizer with the drug, and it could be the first in a number of new HIV drugs to hit the market in the near future. You can see our past coverage here.
The Cycle
For both journalists and communicators, the news cycle never ends. At The Cycle, PRWeek’s editorial team offers commentary and viewpoints on how the latest marketing, business, political, and cultural news impact the PR industry.
RSSThis material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions